Document is current
Any future updates will be listed below
-
Authors
Zieren, Richard C.
Dong, Liang
Clark, David J.
Kuczler, Morgan D.
Horie, Kengo
Moreno, Leandro Ferreira
Lih, Tung-Shing M.
Schnaubelt, Michael
Vermeulen, Louis
Zhang, Hui
de Reijke, Theo M.
Pienta, Kenneth J.
Amend, Sarah R. https://orcid.org/0000-0002-5606-1262
-
Funding
Funding for this research was provided by:
Stichting Cure for Cancer foundation
Japan Society for the Promotion of Science (KAKENHI: 19K18555)
New York Stem Cell Foundation (Robertson Investigator)
National Cancer Institute (U01CA152813, U24CA210985, U54CA143803, CA163124, CA093900, CA143055)
Prostate Cancer Foundation
DOD Prostate Cancer Research Program (W81XWH-20-10353)
- License Information
-
More Information
Article History
Received: 24 May 2021
Accepted: 18 July 2021
First Online: 31 July 2021
Declarations
:
: K.J.P. is founder and holds an equity interest in Keystone Biopharma, Inc., and is the acting CMO of Cue Biopharma, Inc. The other authors have declared no competing interests.
